Hypophosphatemia Clinical Trial
Official title:
Prospective, Multicentre Study to Validate the GastroIntestinal Dysfunction Score (GIDS) and Describe Prevalence, Outcomes, and Management of Phosphate Disorders in Intensive Care Patients
This study will address two specific research questions simultaneously: 1. validation of the GastroIntestinal (GI) Dysfunction score (GIDS). 2. description of epidemiology, risk factors, and management of phosphate disorders. The aim is to recruit 20 ICUs and 1500 ICU patients. Sites will recruit all consecutive adult patients to a maximum of 120 patients or a maximum recruitment period of 8 weeks, whichever comes first. Daily data collection on gastrointestinal signs and symptoms as well as phosphate values and management will be collected during ICU stay for maximum of 7 days. 28 and 90 day mortality and days free of organ support will be the main outcomes. Secondary outcomes include prevalence of hypo- and hyperphosphatemia and description of their management.
Patient population All consecutive adult patients that are admitted to participating ICU during a recruitment period of maximum 8 weeks. Duration of the study for the individual patient: 1. Study period of a maximum of 7 days 2. Follow-up period of a maximum of 90 days All patients will be included in the Part A of the study validating GIDS, patients from sites with routine serum phosphate measurements will be included also in the Part B of the study where additional data on serum phosphate levels and management of phosphate disorders will be collected. There will be no additional measurements due to study participation, daily routine is documented. Baseline characteristics will be collected at ICU admission/study inclusion Daily data include routine data on organ dysfunctions and organ support therapies and specific data on phosphate where available. Outcome data include 28 and 90 days mortality, and days free of organ support by day 28. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04519762 -
Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU
|
Phase 4 | |
| Enrolling by invitation |
NCT04502784 -
Investigation of Hypophosphataemia Following Intravenous Iron
|
||
| Completed |
NCT03529058 -
Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU
|
||
| Terminated |
NCT01011114 -
Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney Transplant
|
N/A | |
| Completed |
NCT05098249 -
Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia
|
Phase 4 | |
| Not yet recruiting |
NCT06350955 -
IV Iron-induced Hypophosphatemia After RYGB
|
Phase 4 | |
| Completed |
NCT00688077 -
FGF-23 Suppressibility by Calcitonin
|
N/A | |
| Recruiting |
NCT04814641 -
Hypophosphatemia and Bronchiolitis
|
||
| Recruiting |
NCT01660308 -
Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia
|
N/A | |
| Active, not recruiting |
NCT03976440 -
Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED: a Pilot Study
|
||
| Completed |
NCT03581591 -
Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets
|
Phase 3 | |
| Completed |
NCT03740802 -
Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis
|
||
| Suspended |
NCT03771105 -
The Impact of Phosphate Metabolism on Healthy Aging
|
Early Phase 1 | |
| Active, not recruiting |
NCT06112236 -
Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special Focus on Hypophosphatemia
|
||
| Completed |
NCT03489993 -
FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP)
|
||
| Completed |
NCT00975000 -
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
|
Phase 3 | |
| Withdrawn |
NCT02837523 -
Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)
|
||
| Not yet recruiting |
NCT06344546 -
Metabolic Pathway Analysis in Intensive Care Unit Patients With Refeeding Syndrome
|